These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7867639)

  • 1. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
    Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
    Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase.
    Berti L; Mosthaf L; Kroder G; Kellerer M; Tippmer S; Mushack J; Seffer E; Seedorf K; Häring H
    J Biol Chem; 1994 Feb; 269(5):3381-6. PubMed ID: 7508912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta.
    Strack V; Hennige AM; Krützfeldt J; Bossenmaier B; Klein HH; Kellerer M; Lammers R; Häring HU
    Diabetologia; 2000 Apr; 43(4):443-9. PubMed ID: 10819237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation.
    Bossenmaier B; Strack V; Stoyanov B; Krützfeldt J; Beck A; Lehmann R; Kellerer M; Klein H; Ullrich A; Lammers R; Häring HU
    Diabetes; 2000 Jun; 49(6):889-95. PubMed ID: 10866039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors.
    Anderson CM; Olefsky JM
    J Biol Chem; 1991 Nov; 266(32):21760-4. PubMed ID: 1657981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
    Schranz DB; Rohilla AM; Anderson C; Wood WM; Berhanu P
    Biochem Biophys Res Commun; 1996 Oct; 227(2):600-7. PubMed ID: 8878559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.
    Thies RS; Ullrich A; McClain DA
    J Biol Chem; 1989 Aug; 264(22):12820-5. PubMed ID: 2753889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol phospho-oligosaccharides from rat fibroblasts and adipocytes stimulate 3-O-methylglucose transport.
    Kellerer M; Machicao F; Berti L; Sixt B; Mushack J; Seffer E; Mosthaf L; Ullrich A; Häring HU
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):699-704. PubMed ID: 8240280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells).
    Kellerer M; Mushack J; Seffer E; Mischak H; Ullrich A; Häring HU
    Diabetologia; 1998 Jul; 41(7):833-8. PubMed ID: 9686926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor.
    Feener EP; Backer JM; King GL; Wilden PA; Sun XJ; Kahn CR; White MF
    J Biol Chem; 1993 May; 268(15):11256-64. PubMed ID: 8496180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor.
    Bossenmaier B; Mosthaf L; Mischak H; Ullrich A; Häring HU
    Diabetologia; 1997 Jul; 40(7):863-6. PubMed ID: 9243110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis.
    McClain DA; Maegawa H; Levy J; Huecksteadt T; Dull TJ; Lee J; Ullrich A; Olefsky JM
    J Biol Chem; 1988 Jun; 263(18):8904-11. PubMed ID: 2837467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling.
    Rolband GC; Williams JF; Webster NJ; Hsu D; Olefsky JM
    Biochemistry; 1993 Dec; 32(49):13545-50. PubMed ID: 8257690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and Shc in HEK 293 cells.
    Strack V; Bossenmaier B; Stoyanov B; Mushack J; Häring HU
    Diabetologia; 1997 Oct; 40(10):1135-40. PubMed ID: 9349593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
    Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
    J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A domain of the insulin receptor required for endocytosis in rat fibroblasts.
    Thies RS; Webster NJ; McClain DA
    J Biol Chem; 1990 Jun; 265(17):10132-7. PubMed ID: 2161833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
    Sasaoka T; Takata Y; Kusari J; Anderson CM; Langlois WJ; Olefsky JM
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4379-83. PubMed ID: 8506276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells.
    Müller HK; Kellerer M; Ermel B; Mühlhöfer A; Obermaier-Kusser B; Vogt B; Häring HU
    Diabetes; 1991 Nov; 40(11):1440-8. PubMed ID: 1657668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.